EPISODE · Oct 2, 2020 · 19 MIN
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
from Decera Clinical Education Oncology Podcast · host Bradley J. Monk MD FACS FACOG, Prof Isabelle Ray Coquard
In this episode, Isabelle Ray Coquard, MD, PhD and Bradley J. Monk, MD, FACS, FACOG, discuss current first-line maintenance therapy options for patients with advanced ovarian cancer. Presenters:Prof Isabelle Ray CoquardProfessor of Department of Medical OncologyClinical Science Institute of the Léon Bérard CenterLyon, FranceBradley J. Monk MD, FACS, FACOGProfessorDivision of Gynecologic OncologyArizona Oncology (US Oncology Network)University of Arizona College of Medicine--PhoenixCreighton University School of Medicine at St Joseph's HospitalPhoenix, ArizonaContent based on an online CME program supported by an educational grant from GlaxoSmithKline.Link to full program:https://bit.ly/2Scnp2N Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
Listen to Prof Isabelle Ray Coquard and Bradley J. Monk, MD, FACS, FACOG, discuss current treatment options for first-line maintenance therapy for patients with advanced ovarian cancer.
NOW PLAYING
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.